2018
DOI: 10.1016/j.tetlet.2018.10.020
|View full text |Cite
|
Sign up to set email alerts
|

An alternative stereoselective synthesis of greensporone C

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…Compound 14 was evaluated for its in vitro TAK1 inhibitory activity and found to be inactive . Interestingly, some of these structures have caught the attention of synthetic chemists, with 14 , , 13 , and 19 being subjected to total synthesis; in those cases the characterization data between synthetic and natural compounds were in agreement. While preparing this manuscript, the total synthesis of compounds 21 and 22 was achieved and the absolute configuration of the stereogenic centers of the tetrahydrofuran rings was established as (5 R ,8 R ) .…”
Section: Part Ii: Chemical Diversity Of Freshwater Fungimentioning
confidence: 99%
“…Compound 14 was evaluated for its in vitro TAK1 inhibitory activity and found to be inactive . Interestingly, some of these structures have caught the attention of synthetic chemists, with 14 , , 13 , and 19 being subjected to total synthesis; in those cases the characterization data between synthetic and natural compounds were in agreement. While preparing this manuscript, the total synthesis of compounds 21 and 22 was achieved and the absolute configuration of the stereogenic centers of the tetrahydrofuran rings was established as (5 R ,8 R ) .…”
Section: Part Ii: Chemical Diversity Of Freshwater Fungimentioning
confidence: 99%
“…In addition, these structural classes represent two different perspectives from the vantage point of natural products drug discovery. In the case of RALs, we, and others, are intrigued by their biological activities, especially against transforming growth factor-β-activated kinase 1 (TAK1). , Our program is actively engaged in discovering new analogues and/or identifying fungal strains that biosynthesize them at a high titer, especially since at least one analogue is in clinical development as a cancer chemotherapeutic. , By contrast, spirobisnaphthalenes are considered “nuisance compounds” in our program. They are encountered somewhat frequently when studying fungi for bioactive metabolites, and, since they typically exhibit only mild cytotoxic activity, we prefer to avoid them …”
mentioning
confidence: 99%